Sabrina Giometto,Mette Reilev,Martin Thomsen Ernst et al.
Sabrina Giometto et al.
Purpose: The length of the time window used to assess "current drug use" or "number of medications used" will influence the estimates hereof; however, no consensus exists on the optimal width of such time windows. We aime...
A Plasmode Simulation-Based Bias Analysis for Residual Confounding by Unmeasured Variables Leveraging Information-Rich Subsets [0.03%]
基于模式仿真未测量混杂因素剩余偏差的信息丰富子集杠杆分析
Rishi J Desai,Shirley V Wang,Haritha S Pillai et al.
Rishi J Desai et al.
Aim: To develop a quantitative bias analysis approach based on realistic assumptions reflective of the complexities of healthcare data. Methods: ...
Beta Blocker Use and Total Knee Arthroplasty Among United States Medicare Beneficiaries [0.03%]
β受体阻滞药使用与美国老年人全膝关节置换术的关系
Shailina Keshwani,Haesuk Park,Wei-Hsuan Lo-Ciganic et al.
Shailina Keshwani et al.
Background/objectives: Preclinical evidence suggests beta blockers may reduce cartilage degradation and delay knee osteoarthritis (OA) progression. While beta blockers are widely used in patients with hypertension, their ...
The Contribution to the Assignment of Defined Daily Dose (DDD) to Antineoplastic Drugs of the Italian Working Group on DDD [0.03%]
意大利定义的每日剂量(DDD)分配工作组对抗肿瘤药物DDD赋值的贡献
Angela Boccia,Giulia Hyeraci,Anna Girardi et al.
Angela Boccia et al.
Purpose: To report the experience of the Italian Working Group on DDD (Ita-DDD-wg) in assigning DDDs to a list of antineoplastic agents. Methods: ...
Comparative Analysis of Potential Side Effects of Targeted Oral Hypoglycemic Agents Using Spontaneous Adverse Event Reports and Social Media Data [0.03%]
基于自发报告的不良事件和社交媒体数据对比分析口服降糖药物潜在不良反应
Se-Hoon Oh,Dong-Young Park,Yun-Kyoung Song
Se-Hoon Oh
Aim: Adverse events (AEs) detected in tweets and in the FDA Adverse Event Reporting System (FAERS) provide valuable insights into patient experiences with oral hypoglycemic agents including sodium-glucose transporter 2 (S...
Comparative Study
Pharmacoepidemiology and drug safety. 2026 May;35(5):e70386. DOI:10.1002/pds.70386 2026
Methodological Characteristics in Economic Evaluations of Health Technology Assessment Reports Submitted for Drug Reimbursement in Brazilian Public Health [0.03%]
巴西公共卫生药物报销的卫生技术评估报告中的经济学评价方法特征分析
Gilson Pires Dorneles,Cintia Pereira de Araujo,Suena Parahiba et al.
Gilson Pires Dorneles et al.
Objectives: To characterize methodological aspects and the quality reporting of economic evaluation in HTA reports of drugs submitted to the Brazilian public health system. ...
The EUROmediCAT Network and Databases: A Resource for Pharmacovigilance in Pregnancy [0.03%]
EUROmediCAT网络和数据库：妊娠期药物警戒资源
Helen Dolk,Christine Damase-Michel,Joan Morris et al.
Helen Dolk et al.
Background: The evidence gap relating to the risk of congenital anomalies (CA) associated with first trimester medication exposure in pregnancy is well recognized. ...
Alain Braillon
Alain Braillon
Identifying the Initiation of a New Line of Therapy for Metastatic Lung, Breast, and Colorectal Cancer in Real-World Data: A Scoping Review [0.03%]
识别真实世界数据中转移性肺癌、乳腺癌和结直肠癌新治疗线开始的标志：系统评价
Oluwadamilola Onasanya,Seyed Hamidreza Mahmoudpour,Benjamin Bates et al.
Oluwadamilola Onasanya et al.
Purpose: This study aimed to identify and synthesize published algorithms for identifying the initiation of a new line of therapy (LOT) for metastatic lung, breast, and colorectal cancer in real-world data (RWD). ...
Analysis of Mandatory Post-Marketing Surveillance Studies Supports Revised Regulatory Requirements in Korea [0.03%]
mandatory post-marketing surveillance studies支持韩国修订监管要求
Kevin Wolter,Seung-Hee Jeong,Ju-Won Woo et al.
Kevin Wolter et al.
Purpose: The objective of this analysis was to determine the contribution to the understanding of product benefit/risk made by non-randomized, observational post-marketing surveillance (PMS) studies previously required by...